Track 17: Heart Disease in Women


5th World Cardiology and Cardiovascular Diseases Conference

Dubai, UAE | March 04–06, 2026

Heart disease is often seen as a men’s health issue, but the reality is far different—cardiovascular disease is the leading cause of death among women worldwide. Despite this alarming statistic, heart disease in women remains underdiagnosed, undertreated, and under-researched.

At the 5th World Cardiology and Cardiovascular Diseases Conference in Dubai, Track 17: Heart Disease in Women will spotlight the unique risk factors, symptoms, and treatment challenges faced by women, while also addressing the urgent need for gender-specific strategies in prevention and care.

Why Focus on Women’s Heart Health?

Women often present with atypical symptoms—such as fatigue, shortness of breath, nausea, or back pain—leading to delayed or missed diagnoses. Hormonal factors, pregnancy-related complications, and conditions such as gestational diabetes, preeclampsia, and autoimmune diseases also contribute to women’s higher cardiovascular risk.

This track will explore:

  • Gender Differences in Cardiovascular Disease – Biology, hormones, and symptom presentation.
  • Pregnancy & Heart Disease – Impact of high-risk pregnancies and long-term cardiovascular health.
  • Preventive Strategies for Women – Lifestyle medicine, screening, and early intervention.
  • Clinical Advances & Treatments – Tailored therapies, minimally invasive procedures, and pharmacological updates.
  • Global Advocacy & Awareness – Addressing gaps in research, policy, and education for women’s cardiovascular health.

Who Should Attend This Track?

  • Cardiologists & Cardiac Specialists
  • Gynecologists & Obstetricians
  • General Physicians & Family Doctors
  • Researchers & Scientists in Gender Medicine
  • Nurses, Midwives & Allied Health Professionals
  • Public Health Experts & Policy Makers

Why Dubai 2026?

With its role as a global hub for innovation and collaboration, Dubai provides the perfect backdrop for this essential discussion. Attendees will gain insights from leading experts, discover new approaches in gender-specific cardiology, and contribute to shaping the future of women’s heart health worldwide.

Join us at the 5th World Cardiology and Cardiovascular Diseases Conference, March 04–06, 2026, in Dubai, UAE, and be part of the global effort to empower women’s heart health and bridge the gaps in cardiovascular care.

 

Comments

Post a Comment

Popular posts from this blog

Track 5: Cardio-Oncology – Where Cancer Care Meets Cardiovascular Precision

Image
5th World Cardiology and Cardiovascular Diseases Conference | March 04–06, 2026 | Dubai, UAE As cancer survival rates continue to rise, so too does a growing and urgent need to address the cardiovascular side effects of cancer therapies . At the intersection of oncology and cardiology lies the rapidly evolving field of Cardio-Oncology —the focus of Track 5 at the upcoming 5th World Cardiology and Cardiovascular Diseases Conference in Dubai, UAE . This dedicated track offers a critical platform to explore how cancer treatments impact the heart, and how healthcare professionals can work together to protect both survival and quality of life for patients. The Rising Relevance of Cardio-Oncology Life-saving cancer treatments such as chemotherapy, immunotherapy, radiation, and targeted agents often come with unintended cardiovascular risks—ranging from arrhythmias and hypertension to heart failure and myocardial ischemia. With the number of cancer survivors growing worldwide,...
Read more

Track 20: Diabetic Cardiomyopathy

Image
Track 20: Diabetic Cardiomyopathy 5th World Cardiology and Cardiovascular Diseases Conference Dubai, UAE | March 04–06, 2026 Diabetic cardiomyopathy (DCM) is a growing global concern that highlights the intricate link between diabetes and cardiovascular health . Characterized by structural and functional changes in the heart muscle in patients with diabetes—independent of coronary artery disease or hypertension—DCM is emerging as a major contributor to heart failure in diabetic populations. At the 5th World Cardiology and Cardiovascular Diseases Conference in Dubai , Track 20: Diabetic Cardiomyopathy will delve into the pathophysiology, diagnostic strategies, and therapeutic approaches to tackle this complex condition. With the rapid increase in diabetes worldwide, understanding and managing DCM is more critical than ever. Key Topics of Discussion Molecular Mechanisms – Hyperglycemia, oxidative stress, and myocardial fibrosis in DCM. Diagnosis & Imaging – The role of ech...
Read more

Track 22: Cardiac Devices and Diagnostics

Image
5th World Cardiology and Cardiovascular Diseases Conference Dubai, UAE | March 04–06, 2026 The field of cardiology has been transformed by innovative devices and advanced diagnostic technologies that enable earlier detection, more accurate monitoring, and more effective treatment of cardiovascular diseases. From wearable technologies and implantable devices to state-of-the-art imaging tools and AI-powered diagnostics , these advancements are revolutionizing patient outcomes and quality of life. At the 5th World Cardiology and Cardiovascular Diseases Conference in Dubai , Track 22: Cardiac Devices and Diagnostics will showcase the latest progress in medical devices, monitoring systems, imaging modalities, and diagnostic strategies that are shaping the future of cardiovascular care. Key Topics of Discussion Implantable Cardiac Devices – Pacemakers, defibrillators, and ventricular assist devices. Wearable & Remote Monitoring – Smartwatches, biose...
Read more